Biotech Stocks Burn A Hole In Big Pharma's Pocket. Look For More In 2020Investors Business Daily • 12/13/19
Sanofi Is Paying a 172% Premium to Buy Synthorx -- and It Sounds Like a Good Deal for BothThe Motley Fool • 12/10/19
Regeneron Shares Swing On Sanofi's Hint At Sale Of Ownership Stake, Amendments To Drug CollaborationsBenzinga • 12/10/19
Sanofi's Positive Diabetes Study Offers A New Treatment Alternative For PatientsSeeking Alpha • 11/21/19